Posts From September, 2022

Merck owns U.S. Patent 7,326,708, which describes sitagliptin dihydrogenphosphate, a dipeptidyl peptidase-IV (“DP-IV”) inhibitor, which can be used for treating non-insulin-dependent (i.e.,...

Cooperative sued Kollective for infringement of U.S. Patent No. 9,432,452 relating to systems and methods of structuring a peer-to-peer (P2P) dynamic network...

Weber petitioned for inter partes review (“IPR”) of claims 1–14 of Provisur’s U.S. Patent No. 6,997,089 relating to methods and systems for...

Polaris filed a complaint accusing NVIDIA of infringing certain claims of U.S. Patent Nos. 6,532,505...

Sawstop appeals the District Court’s denial of its challenge to the PTO’s interpretation of  35 U.S.C. §...

Hyatt filed U.S. Patent Application No. 08/435,938, which claims priority to applications filed as early as 1983, during the GATT...

Arendi sued LG alleging that various LG products infringed U.S. Patent No. 7,917,843. The local...